Studies related to Rate of Sickness and Echinacea

Echinacea Root Extracts For The Prevention Of Upper Respiratory Tract Infections: A Double-blind, Placebo-controlled Randomized Trial

Effect Decrease
Values Upper respiratory tract infections. % and 95% CI who had at least one infection. Placebo: 37% (27%-47%) Angustifolia, 32% (23%-41%) Purpurea: 29% (20%-38%) Mean and 95% CI days until first influence. Placebo: 65 (59-70) Angustifolia: 66 (61-72) Purpurea: 69 (64-74)
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 113
Sex Both Genders
Notes for this study:
In a randomized, double-blind, placebo-controlled trial, 302 participants were given 50 drops twice daily of a 30$ ethanol 1:11 plant:extract product of echinacea Angustifolia, echinacea purpura, or placebo for 12 weeks

There were 113 upper respiratory tract infections but while there were fewer in the echinacea groups, the difference compared with the placebo wasn't statistically significant.

Full details on all 3 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.